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Chronic alcohol exposure reduces endocannabinoid activity and disrupts adult
neurogenesis in rodents, which results in structural and functional alterations.
Cannabinoid receptor agonists promote adult neural progenitor cell (NPC) proliferation.
We evaluated the protective effects of the selective CB1 receptor agonist ACEA,
the selective CB2 receptor agonist JWH133 and the fatty-acid amide-hydrolase
(FAAH) inhibitor URB597, which enhances endocannabinoid receptor activity, on NPC
proliferation in rats with forced consumption of ethanol (10%) or sucrose liquid diets
for 2 weeks. We performed immunohistochemical and stereological analyses of cells
expressing the mitotic phosphorylation of histone-3 (phospho-H3+) and the replicating
cell DNAmarker 5-bromo-2’-deoxyuridine (BrdU+) in the main neurogenic zones of adult
brain: subgranular zone of dentate gyrus (SGZ), subventricular zone of lateral ventricles
(SVZ) and hypothalamus. Animals were allowed ad libitum ethanol intake (7.3 ± 1.1
g/kg/day) after a controlled isocaloric pair-feeding period of sucrose and alcoholic diets.
Alcohol intake reduced the number of BrdU+ cells in SGZ, SVZ, and hypothalamus.
The treatments (URB597, ACEA, JWH133) exerted a differential increase in alcohol
consumption over time, but JWH133 specifically counteracted the deleterious effect of
ethanol on NPC proliferation in the SVZ and SGZ, and ACEA reversed this effect in
the SGZ only. JWH133 also induced an increased number of BrdU+ cells expressing
neuron-specific β3-tubulin in the SVZ and SGZ. These results indicated that the specific
activation of CB2 receptors rescued alcohol-induced impaired NPC proliferation, which
is a potential clinical interest for the risk of neural damage in alcohol dependence.
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Introduction
The excessive consumption of alcohol is associated with
alterations in brain physiology, structure and function. Alcohol-
induced neurodegeneration and cognitive deficits occur due
to neuronal cell death and the loss of neurogenesis in acute
and chronic alcohol intoxication (Nixon and Crews, 2004).
Consequently, individuals with alcohol dependence exhibit
significant volume loss in cortical and subcortical brain
structures, including gray and white matter shrinkage (White,
2003; Crews and Nixon, 2009). A thinning of the granular layer
of the dentate gyrus in animal models of alcohol exposure is
attributed to neuronal loss and a decrease in newborn cells,
which contributes to impairments in hippocampus-dependent
tasks (Santín et al., 2000; Roberto et al., 2002; Herrera et al.,
2003; Shors et al., 2012). The mechanisms underlying alcohol-
induced neuronal damage and death are complex and not
well understood. Proposed explanations include excitotoxicity
associated with excessive neurotransmitter release and oxidative
stress. The endocannabinoid system in the most sensitive
corticolimbic brain regions, such as the hippocampus, tightly
regulates these processes (Crews et al., 2004; Katona and Freund,
2012).
The endocannabinoid system is a growing interest because
it mediates neuroprotective effects after damage, and it affects
neural stem cell proliferation (Stella, 2010; Katona and Freund,
2012; Galve-Roperh et al., 2013; Bandiera et al., 2014).
The activation of the cannabinoid receptors (CB1 and CB2
receptors) and the inhibition of theN-acylethanolamides (NAEs)
hydrolyzing enzyme FAAH promote neural proliferation, which
was observed in aged mouse brains (Aguado et al., 2005;
Goncalves et al., 2008). Therefore, CB1 receptor activation
promotes neuronal differentiation and maturation and protects
neurons from brain injury (Parmentier-Batteur et al., 2002;
Marsicano et al., 2003; Fowler et al., 2010; Compagnucci et al.,
2013). Selective CB2 receptor stimulation prevents deficits in
neurogenesis, microglial activation and cognitive impairment,
including the undesired psychoactive effects of neuronal CB1
receptor activation (Ashton and Glass, 2007; Goncalves et al.,
2008; Stella, 2010; Palazuelos et al., 2012; Rom and Persidsky,
2013; Avraham et al., 2014).
Most studies suggested reduced brain cannabinoid activity
during alcohol consumption, likely from the low expression
levels of the CB1 and CB2 receptors (Basavarajappa, 2007;
Ishiguro et al., 2007; Serrano et al., 2012). The impairment
of neurogenesis during alcohol intoxication may be associated
Abbreviations: 3v, third ventricle; ACEA, arachidonyl-2′-chloroethylamide; ARC,
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Chemical compounds studied in this article:URB597 (PubChem CID: 1383884);
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with a reduced cannabinoid activity (Ortiz et al., 2004; Ferrer
et al., 2007; Crews and Nixon, 2009; Rubio et al., 2009),
and the potential positive modulation of neurogenic responses
promoted by the exogenous administration of cannabinoid
receptor agonists may be beneficial in alcoholism. However, one
of the major concerns against the use of this class of compounds
arose from results that demonstrated that the CB1 receptor
agonists CP 55,940 and WIN 55,212-2, which bind both CB1
and CB2 receptors with similar affinities, may increase voluntary
alcohol consumption and alcohol drinking motivation, which
were specifically observed in Sardinian alcohol-preferring (sP)
rats (Hungund et al., 2003; Colombo et al., 2005). In contrast,
other studies indicated that novel and selective agonists for CB1
or CB2 receptors may exhibit beneficial effects in alcoholism,
such as anti-oxidant activity in the liver (Tsvetanova et al.,
2006) or reduced alcohol intake and preference (Vasiljevik et al.,
2013; Al Mansouri et al., 2014). Discrepancies also exist for
modulators of endocannabinoid tone when these agents were
administered in distinct experimental models of alcohol exposure
(Serrano and Parsons, 2011). For example, administration of the
FAAH inhibitor URB597 into the prefrontal cortex increased
alcohol intake in rodents (Basavarajappa et al., 2006; Hansson
et al., 2007; Vinod et al., 2008). However, the intraperitoneal
administration of URB597 did not show an alcohol abuse risk,
and it reduced anxiety associated to alcohol withdrawal inWistar
and sP rats (Cippitelli et al., 2008). The AEA transport inhibitor
AM404 reduced alcohol self-administration (Cippitelli et al.,
2007). However, whether the selective activation of cannabinoid
CB1 and CB2 receptors or the pharmacological elevation of
endocannabinoid tone counteract cell proliferation impairment
in the adult brain of rats exposed to alcohol is not known.
The present study designed an experimental approach to
investigate the protective effects of the repeated administration
(5 days) of the FAAH inhibitor URB597 (at an effective dose
of 0.3mg/kg; Piomelli et al., 2006), ACEA (3mg/kg) and
JWH133 (0.2mg/kg) on brain structures that display NPC
proliferation in alcohol-exposed rats. Immunohistochemistry
and stereology assessed cells that expressed the mitotic Ser-10
phosphorylation of histone-3 (phospho-H3+) and contained the
replicating cell DNA marker 5-bromo-2′-deoxyuridine (BrdU+)
in the main neurogenic zones [subgranular zone of dentate
gyrus (SGZ), subventricular zone of lateral ventricles (SVZ) and
hypothalamus] in adult rats with a forced consumption of ethanol
(10%) and sucrose liquid diets for 2 weeks. Precursor and mature
phenotyping of the BrdU+ cells was also evaluated.
Materials and Methods
Ethics Statement
The Ethics and Research Committee at the Universidad
de Málaga approved the protocols for animal care and
use. All experimental animal procedures were performed in
strict accordance with the European Communities directive
86/609/ECC (24 November 1986) and Spanish legislation (BOE
252/34367-91, 2005) regulating animal research. All efforts were
made to minimize animal suffering and reduce the number of
animals used.
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Animals
Male Wistar rats (approximately 250 g, 10–12 weeks old; Charles
Rivers, Barcelona, Spain) were housed individually in cages
and maintained in standard conditions (Servicio de Estabulario,
Facultad de Medicina, Universidad de Málaga) at 20± 2◦C room
temperature with 40± 5% relative humidity and a 12-h light/dark
cycle with a dawn/dusk effect. Water and standard rodent chow
(Prolab RMH 2500, 2.9 kcal/g) were available ad libitum, unless
otherwise indicated for specific experimental procedures.
Alcoholic diet habituation
Rats were first food-deprived to 95% of their free-feeding weight,
and they were allowed ad libitum access to a complete and
balanced chocolate-flavored liquid food (0.97 kcal/mL; Glucerna
SR, Abbott Laboratories, Madrid, Spain) until a stable rate of
feeding was reached (∼50mL/day, up to 2–3 days). Rats were
divided into two groups (n = 24) and fed the chocolate-
flavored liquid diet supplemented with 10% (v/v) ethanol
(alcoholic liquid diet) or 14.7% (w/v) sucrose (sucrose liquid
diet; Serrano et al., 2012). Alcoholic and sucrose liquid diets
were formulated to contain the same calories (1.4 kcal/mL).
The same volume of ethanol liquid diet consumed ad libitum
was given the next day to the rats fed the sucrose liquid diet.
The rats were maintained under a controlled-isocaloric pair
feeding period until a stable rate of alcoholic consumption was
reached (12.4 ± 1.4 g of ethanol/kg body weight/day, up to 1
week). Water was available ad libitum during experimentation.
Cumulative intake and body weight gain were periodically
monitored.
Administrations of URB597, ACEA, and JWH133
Rats were fed ad libitum with both liquid diets (ethanol
or sucrose) after alcoholic diet habituation. The following
drugs were intraperitoneally administered: FAAH inhibitor
URB597 (cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-
yl ester, IC50 = 3 − 5 nM; Cayman Chemical, cat. no.
10046, Ann Arbor, MI, USA), the potent and highly selective
CB1 receptor agonist ACEA (arachidonyl-2′-chloroethylamide,
Ki = 1.4 nM; Tocris, cat. no. 1319), and the potent and
selective CB2 receptor agonist JWH133 (Ki = 3.4 nM;
Tocris, cat. no. 1343). Drugs were dissolved in a vehicle
containing 33% (v/v) DMSO in a sterile 0.9% NaCl solution
and administered in a final volume of 1mL/kg body weight.
We selected the optimal dose at which treatment would be
more effective in neuroprotection, as previously described
(Piomelli et al., 2006; Goncalves et al., 2008; Galan-Rodriguez
et al., 2009). URB597, ACEA and JWH133 were repeatedly
administered at doses of 0.3, 3, and 0.2mg/kg body weight,
respectively, for 5 consecutive days at 24-h intervals (8:00
a.m.). The animals were sacrificed 2 h after the last drug
injection. We obtained eight experimental groups depending
on the diet and treatment (n = 6): vehicle-treated sucrose-
fed group, URB597-treated sucrose-fed group, ACEA-treated
sucrose-fed group, JWH133-treated sucrose-fed group, vehicle-
treated ethanol-fed group, URB597-treated ethanol-fed group,
ACEA-treated ethanol-fed group and JWH133-treated ethanol-
fed group (Figure 1).
BrdU Administration
5′-bromo-2′-deoxyuridine (BrdU, cat. no. B5002, Sigma, St.
Louis, MO, USA) was dissolved at 15mg/mL in a sterile 0.9%
NaCl solution. BrdU was administered intraperitoneally (i.p.)
during the ad libitum feeding period at a dose of 50mg/kg
body weight twice daily at 10-h intervals (08:00, 18:00 h) for 4
consecutive days (Cifuentes et al., 2011).
Sample Collection
All animals were anesthetized (sodium pentobarbital, 50mg/kg
body weight, i.p.) 2 h after the last dose of treatment. Blood
samples were transcardially collected into tubes containing
EDTA-2Na (1mg/mL blood) and centrifuged (1600 g for 10min,
4◦C). Plasma was frozen and stored at −80◦C for biochemical
analyses. Brains were frozen at -80◦C and prepared on dry ice to
obtain 1-mm thick sections using razor blades and a rat brain
slicer matrix. The striatum, hippocampus and hypothalamus
were precisely removed from 2.28 to −0.24mm and −2.16
to −4.20mm from Bregma levels (Paxinos and Watson, 2007)
using fine surgical instruments. Brain samples were weighed
and stored at −80◦C until use in liquid chromatography—
multiple reaction monitoring (LC-MRM) analyses. A replicated
batch of rats were transcardially perfused with 4% formaldehyde
in 0.1M phosphate buffer (PB), and the brains were dissected
and kept in the same fixative solution overnight at 4◦C.
These brains were cryoprotected and cut into 30-µm-thick
coronal sections using a sliding microtome (Leica VT1000S).
Sections were divided in eight parallel series until use for
immunostaining.
Anandamide Quantification
We performed a quantitative analysis of plasma and brain
anandamide (AEA) following a recently published protocol
by Lomazzo et al. (2015) with slight modification to
assess the inhibition of FAAH activity by URB597. Plasma
endocannabinoid extract was resuspended in 50µL (1:1,
ACN:H20), and an aliquot was diluted 1:5 (1:1, ACN:H20) prior
to injection in the LC/MRM. Aliquots (20µL) were injected.
AEA values were normalized to the starting plasma volume
or the tissue weight used for extraction (see Supplementary
Material).
Biochemical and Enzymatic Analysis
The hepatic enzymes gamma-glutamyl transpeptidase (γGT),
glutamate pyruvate transaminase (GPT) and glutamic
oxaloacetic transaminase (GOT), and creatinine and bilirubin
were analyzed using commercial kits according to the
manufacturer’s instructions in a Hitachi 737 Automatic
Analyzer (Hitachi Ltd., Tokyo, Japan). A calibration curve and
internal controls were included in each assay.
Immunohistochemistry
Free-floating coronal sections from −2.16 to −4.20 Bregma
levels (hippocampus and hypothalamus) and 2.28 to -0.24
Bregma levels (striatum) of each parallel series were selected
for each immunohistochemistry (Rivera et al., 2015). Sections
were incubated overnight in the following diluted primary
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FIGURE 1 | Time line of the experimental design that summarize the periods of feeding and treatment used in the present study.
antibodies at 4◦C: rabbit anti-phospho-histone H3 (Ser-10;
2µg/ml, Upstate, cat. no. 06-570) and mouse anti-BrdU
(1:2000, Hybridoma Bank, Iowa City, IA, USA; ref. G3G4;
Cifuentes et al., 2011; Rivera et al., 2011, 2013). Sections were
incubated in the respective secondary antibody for 90min:
biotinylated goat anti-mouse IgG (1:500, Sigma; cat. no. B7264)
or biotinylated donkey anti-rabbit IgG (1:500, Amersham,
Little Chalfont, England; cat. no. RPN 1004). The sections
were incubated in ExtrAvidin peroxidase (Sigma, St. Louis,
MO) diluted 1:2000 in darkness at room temperature for 1 h.
Immunolabeling was revealed with 0.05% diaminobenzidine
(DAB; Sigma), 0.05% nickel ammonium sulfate and 0.03% H2O2
in PBS.
Stereological Cell Quantification
The average density of immunoreactive cells per animal was
quantified using stereological methods. Estimations of the
number of cells per section (30µm deep) and area (mm2) in
both hemispheres was calculated according to the following
formula: Na = 6(Q−)/6(astr), where 6Q- is the total
number of positive cells counted per animal, and astr is the
area of the structure analyzed. Each structure analyzed consisted
of approximately 8 coronal sections, which resulted in one
of every eight equidistant sections (one representative section
for each 240µm) according to the rostro-caudal extent. A
region of interest was drawn in each structure in Bregma -
2.16 to −4.20mm at hippocampal and hypothalamic levels
and Bregma 2.28 to −0.24mm at striatal levels, according to
a rat brain atlas and cytoarchitectonic criteria (Paxinos and
Watson, 2007). Phospho-H3 and BrdU-immunoreactive (-ir)
nuclei that came into focus were manually counted in the
SGZ and SVZ. Counting in the hypothalamus was performed
in the ventromedial (VMH) and arcuate (ARC) nuclei of
the hypothalamus and median eminence. Quantifications were
performed using a standard optical microscope with the 40x
objective (Nikon Instruments Europe B.V., Amstelveen, The
Netherlands) coupled to NIS-Elements Imaging Software 3.00
(Nikon). Data are expressed as the percentage of positive cells
per area (mm2) relative to the control group (vehicle-treated
sucrose-fed rat group).
Double Immunofluorescence
The following primary antibodies were used for double
immunofluorescence: rat anti-BrdU (1:500; Accurate Chemical
& Scientific, Westbury, NY, USA, cat. no. OBT0030G), rabbit
anti-phospho-histoneH3 (1:500; Upstate, cat. no. 06-570), mouse
anti-GFAP (1:500; Sigma, cat. no. G3893) and mouse anti-β3
tubulin (1:400; Promega, Madison, WI, USA). Sections were
incubated overnight at 4◦C with a cocktail of primary antibodies
(BrdU+phospho-H3, BrdU+GFAP or BrdU+β3-tubulin). The
following secondary antibodies were used when appropriate:
donkey anti-rat IgG (H+L) labeled with Alexa Fluor R© 488 (1:500;
Molecular Probes, Invitrogen, Paisley, UK, cat. no. A21208),
donkey anti-rabbit IgG (H+L) labeled with Cy™3 (1:300; Jackson
Immunoresearch, West Grove, PA, USA, cat. no. 711-166-152)
and donkey anti-mouse IgG (H+L) labeled with Alexa Fluor R©
594 (1:500; Molecular Probes, cat. no. A21203). Sections were
incubated for 2 h at room temperature with the appropriate
cocktail of secondary antibodies. Sections were visualized using
a confocal laser (spectral) scanning microscope (Leica TCS
NT; Leica Microsystems) equipped with a 561 nm DPM laser
(argon 30%) and a 63x objective (HCX PL APO CS 63.0x1.40
OIL UV). The emission filter settings were 504–545 nm for
PMT2 (green) and 605–675 nm for PMT3 (red). Settings of
light and brightness/contrast were adjusted using Leica LAS AF
Lite imaging software. Quantification of cells showing single
and double immunofluorescence was performed using several
representative images of the SGZ, SVZ, and hypothalamus
following the procedures described above. Data are expressed
as the percentage of the total number of labeled cells that were
counted per brain region.
Statistical Analysis
Statistical analysis of the results was performed using GraphPad
Prism version 5.04 (GraphPad Software Inc., San Diego, CA,
USA). Data are represented as the mean ± s.e.m. for at least
six determinations per experimental group. Statistical analyses
were performed using repeated measures ANOVA and two-
way ANOVA with the two factors being time and diet (sucrose
and ethanol), time and treatment (vehicle, URB597, ACEA, and
JWH133) and diet and treatment, when appropriate, followed by
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Bonferroni post-hoc test for multiple comparisons. P < 0.05 was
considered significant.
Results
Effects of URB597, ACEA, and JWH133 on
Ethanol Consumption
Rats were habituated to a controlled-isocaloric pair-feeding
period of sucrose and alcohol diets until a stable rate of alcoholic
consumption was reached (12.4 ± 1.4 g of ethanol/kg body
weight/day, up to 1 week). All rats were fed ad libitum for 6 days
after habituation (Figure 1). Bonferroni’s multiple comparison
test following the repeated measures ANOVA analysis indicated
significant increases in the cumulative intake of sucrose diet when
all time points during these 6 days were compared (###P <
0.001). However, an increase in the cumulative intake of alcohol
diet was detected from day 13 onward (day 13: $$P < 0.01; day
14 on: $$$P < 0.001). Two-way ANOVA analysis revealed a clear
diet effect when ad libitum sucrose and alcohol consumptions
were compared [average: 30.6 ± 1.3 vs. 7.3 ± 1.1 g/kg/day;
Cumulative intake: F(1, 60) = 1104.4, P < 0.0001]. A time
effect [F(5, 60) = 204.8, P < 0.0001] and interaction between
diet and time [F(5, 60) = 97.5, P < 0.0001] were found, which
indicates that the increased cumulative consumption of sucrose
and alcohol were different over time. Bonferroni analysis revealed
an increased sucrose intake compared to alcohol intake from the
first day of ad libitum consumption (day 10: P < 0.05; day 11:
P < 0.01; day 12 on: P < 0.001; Figure 2A).
The treatment effect on the cumulative consumption of
sucrose and alcohol was evaluated from the day 11 on. Treatment
effects of URB597, ACEA, and JWH133 on sucrose intake were
detected [F(1, 50) > 184.2, P < 0.0001]. The presence of
time effects [F(4, 50) > 390.2, P < 0.0001] indicated that the
cumulative consumption of sucrose was different over time.
An interaction between treatment and time was also observed
[F(4, 50) > 6.5, P < 0.0003], which indicates that the cumulative
consumption of sucrose changed over time in a treatment-
dependent manner. Bonferroni analyses revealed that URB597
and JWH133 increased sucrose intake from the first day of
treatment (day 11 on) and ACEA increased intake from the
second day (day 12 on) compared to the vehicle group (P < 0.001
from day 12; Figure 2B).
Treatment effects of URB597, ACEA, and JWH133 on
cumulative alcohol intake were also observed [F(1, 50) > 8.5, P <
0.005]. Time effects on cumulative consumption in all treated rats
FIGURE 2 | Effects of the repeated administration of URB597 (0.3mg/kg), ACEA (3mg/kg), and JWH133 (0.2mg/kg) on the cumulative ad libitum
consumption of sucrose and ethanol. (A) Compared consumption of sucrose and ethanol. (B) Treatment effects on sucrose consumption. (C) Treatment effects
on ethanol consumption. The histograms represents the mean + s.e.m. (n = 6) per experimental group. Bonferroni’s test following repeated measures ANOVA:
###P < 0.001 vs. the backward time points; $$/$$$P < 0.01/0.001 vs. day 10; &&/&&&P < 0.01/0.001 vs. day 11; P < 0.01 vs. day 12. Bonferroni’s test
following two-way ANOVA: *P < 0.05, **P < 0.01, ***P < 0.001 vs. the sucrose-vehicle or ethanol-vehicle groups at the same time point.
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were detected [F(4, 50) > 24.32, P < 0.0001], which indicates
that the cumulative consumption of alcohol was different over
time. The lack of interaction between factors suggests that the
treatment similarly affected cumulative alcohol consumption
over time. Bonferroni analysis demonstrated that URB597 and
ACEA increased cumulative alcohol intake from the third day
of treatment on compared to the vehicle group (URB597: day
13, P < 0.05; day 14, P < 0.01, day 15, P < 0.001; ACEA:
day 13, P < 0.01; day 14, P < 0.05, day 15, P < 0.01).
However, no statistical significance was obtained after the day-
to-day analysis of JWH133 despite the overall treatment effect
observed (Figure 2C).
Effects of Ethanol, URB597, ACEA, and JWH133
on Hepatic Transaminases, Bilirubin and
Creatinine
We evaluated the hepatic enzymes gamma-glutamyl
transpeptidase (γGT), glutamate pyruvate transaminase (GPT)
and glutamic oxaloacetic transaminase (GOT), and bilirubin and
creatinine in the plasma of sucrose and alcohol-fed rats to better
understand the alcohol-associated toxicity and the putative
protective role of cannabinoid activity (Table 1). Unbalanced
levels of hepatic transaminases in plasma are generally a
diagnostic indication of alcohol intoxication, and bilirubin and
creatinine are important indicators of hepatic pro-oxidant ability
and renal filtration, respectively.
Diet effects on the GPT/GOT ratio in URB597-, ACEA-, and
JWH133-treated rats were found [URB597: F(1, 20) = 5.9, P =
0.024; ACEA: F(1, 20) = 5.1, P = 0.035; JWH133: F(1, 20) =
9.5, P = 0.005]. We only detected an alcohol effect on the
plasma levels of bilirubin in URB597-treated rats [F(1, 20) =
13.5, P = 0.001]. No alcohol effect was observed on the plasma
levels of γGT or creatinine. We detected treatment effects of
URB597 and JWH133 on the plasma levels of bilirubin [URB597:
F(1, 20) = 13.3, P = 0.0016; JWH133: F(1, 20) = 5.5, P =
0.028]. We also observed treatment effects of URB597 and
JWH133 on plasma creatinine levels [URB597: F(1, 20)= 30.4,
P < 0.0001; JWH133: F(1, 20) = 10.4, P = 0.004]. The plasma
TABLE 1 | Effects of ethanol, URB597, ACEA, and JWH133 on hepatic
transaminases, bilirubin and creatinine in plasma.
γGT GPT/GOT Bilirubin Creatinine
(U/L) ratio (mg/dL) (mg/dL)
Sucrose Vehicle 6.06± 0.56 0.22±0.03 0.83± 0.06 0.96±0.1
URB597 8.13± 0.79* 0.3±0.03 0.49± 0.07** 0.66±0.05*
ACEA 7.93± 0.52* 0.31±0.02* 1.03± 0.25 0.87±0.11
JWH133 6.63± 0.27 0.36±0.03** 0.79± 0.04 0.76±0.08
Ethanol Vehicle 7.63± 0.25* 0.42±0.06* 0.9± 0.04 0.99±0.02
URB597 7.9± 1.06 0.42±0.1 0.84± 0.02# 0.57±0.04###
ACEA 7.15± 0.72 0.33±0.06 0.77± 0.07 0.86±0.004##
JWH133 6.61± 0.63 0.42±0.02* 0.63± 0.09# 0.68±0.07##
Bonferroni analysis: * P < 0.05, ** P < 0.01 vs. sucrose-vehicle group; # P < 0.05 vs.
ethanol-vehicle group.
levels of γGT and GPT/GOT ratio did not exhibit any treatment
effects. Interactions between diet and treatment were specifically
observed in the γGT levels of ACEA-treated rats [F(1,20) =
4.6, P = 0.043] and the bilirubin levels of URB597-treated rats
[F(1, 20) = 6.4, P = 0.019].
Bonferroni analyses indicated that alcohol increased the
plasma levels of γGT and the GPT/GOT ratio (∗P < 0.05;
Table 1). URB597 and ACEA increased the plasma levels of γGT
(∗P < 0.05), ACEA and JWH133 increased the GPT/GOT ratio
(∗P < 0.05, ∗∗P < 0.01, respectively), and URB597 decreased
the plasma levels of bilirubin and creatinine (∗∗P < 0.01, ∗P <
0.05, respectively) in sucrose-fed rats (Table 1). URB597 and
JWH133 decreased the plasma levels of bilirubin (#P < 0.05),
and URB597, ACEA, and JWH133 decreased plasma creatinine
levels (###P < 0.001, ##P < 0.01, ##P < 0.01, respectively) in
ethanol-fed rats (Table 1).
Effects of Ethanol, URB597, ACEA, and JWH133
on NPC Proliferation
We evaluated the percentage of neural proliferating cells that
expressed the mitotic phosphorylation of (Ser-10)-histone 3
(phospho-H3+) and contained the replicating cell DNA marker
5-bromo-2′-deoxyuridine (BrdU+) in the main neurogenic
zones of the adult brain (SGZ, SVZ, and hypothalamus).
No alcohol effects on the number of phospho-H3+ cells were
detected in the SGZ or hypothalamus. No alcohol effects on the
number of BrdU+ cells in SVZ of treated rats were detected.
However, we observed alcohol effects on the number of BrdU+
cells in the SGZ of URB597-, ACEA-, and JWH133-treated rats
[F(1, 32) > 11.64, P < 0.0018] and the hypothalamus of URB597-
and JWH133-treated rats [F(1, 32) > 11.83, P < 0.0016]. An
alcohol effect on the number of phospho-H3+ cells in ACEA-
treated rats was specifically observed in the SVZ [F(1, 32) = 12.38,
P = 0.001] (Table 2).
TABLE 2 | Summary of the effects of diet, treatment and interaction
observed on NPC proliferation after two-way ANOVA analysis.
SGZ SVZ Hypothalamus
Phospho-H3 BrdU Phospho-H3 BrdU Phospho-H3 BrdU
URB597
Diet ns ** ns ns ns **
Treatment ns ns ns ns ns ns
Interaction ns ns * * ns ns
ACEA
Diet ns *** ** * ns ns
Treatment *** ** ns *** ns ***
Interaction ns ns * ns ns ns
JWH133
Diet ns ** ns ns ns ***
Treatment *** *** *** *** * **
Interaction ns ns ns ** ns ns
Two-way ANOVA: * P < 0.05; ** P < 0.01; *** P < 0.001; ns, no significance. Direction of
the change: , increased levels; , decreased levels.
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Treatment effects of ACEA and JWH133, but not URB597,
on the number of phospho-H3+ and BrdU+ cells in the SGZ
were observed [ACEA: F(1, 32) > 12.04, P < 0.0015; JWH133:
F(1, 32) > 22.53, P < 0.0001] (Table 2). We specifically found
effects of JWH133 on the number of phospho-H3+ and BrdU+
cells in the SVZ and hypothalamus [SVZ: F(1, 32) > 25.54, P <
0.0001; hypothalamus: F(1, 32) > 5.27, P < 0.02]. ACEA effects
on the number of BrdU+ cells were also observed in these areas
[SVZ: F(1, 32) = 4.62, P = 0.039; hypothalamus: F(1, 32) = 14.63,
P = 0.0006]. These data suggest similar effects of the selective
activation of CB1 and CB2 receptors on cell proliferation in
the SGZ, SVZ, and hypothalamus in a diet-independent manner
(Table 2).
We did not find interactions between factors (diet and
treatment) when we analyzed the number of phospho-H3+
and BrdU+ cells in the SGZ and hypothalamus of treated rats.
Interactions were detected in the SVZ when we statistically
analyzed the number of phospho-H3+ cells in URB597- and
ACEA-treated rats [F(1, 32) > 5.22, P < 0.029] and the
number of BrdU+ cells in URB597-treated rats [F(1, 32) = 4.97,
P = 0.033]. These results indicated that treatment primarily
affected SVZ cell proliferation in a diet-dependent manner
(Table 2).
Bonferroni analyses for multiple comparisons indicated
that ethanol did not produce any changes in the percentage
of phospho-H3+ cells in the SVZ (∗P < 0.05), SGZ
(∗∗∗P < 0.001) or hypothalamus (∗P < 0.05; Figures 3A–C).
JWH133 increased the percentage of phospho-H3+ in
the SVZ of sucrose- (∗P < 0.05) and ethanol-fed rats
(###P < 0.001; Figure 3A). ACEA and JWH133 increased
the percentage of phospho-H3+ cells in the SGZ of sucrose-
(∗∗P < 0.01, ∗P < 0.05, respectively) and ethanol-fed
rats (#P < 0.05, ###P < 0.001, respectively; Figure 3B).
JWH133 increased the percentage of phospho-H3+ in the
FIGURE 3 | Effects of the repeated administration of URB597 (0.3mg/kg), ACEA (3mg/kg), and JWH133 (0.2mg/kg) on cells that expressed the mitotic
Ser-10 phosphorylation of histone-3 (phospho-H3+) in the SVZ (A), SGZ (B), and hypothalamus (C) of adult rats with sucrose and alcohol consumption.
The data were expressed as the percentage of positive cells per area (mm2) relative to the control group (vehicle-treated sucrose-fed group). The histograms
represents the mean + s.e.m. (n = 6). Bonferroni’s test: *P < 0.05, **P < 0.01 vs. sucrose-vehicle group; #P < 0.05, ###P < 0.001 vs. ethanol-vehicle group.
(D–Z’) Representative microphotographs showing low and high (insets) magnification views of cells expressing phospho-H3 (arrowheads) in the SGZ, SVZ, and
hypothalamus of vehicle, URB597, ACEA, and JWH133-treated rats fed with sucrose (left panel) and ethanol (right panel) diets. Scale bars are included in each image.
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hypothalamus of sucrose-fed rats (∗P < 0.05; Figure 3C).
Representative images of the labeling in the SVZ, SGZ, and
hypothalamus of each experimental group are shown in
Figures 3D–Z′.
Bonferroni analyses for multiple comparisons indicated that
ethanol induced a decrease in the percentage of BrdU+ cells in
the SVZ (∗P < 0.05), SGZ (∗∗∗P < 0.001), and hypothalamus
(∗P < 0.05; Figures 4A–C). JWH133 increased the percentage
of BrdU+ cells in the SVZ and SGZ of sucrose- and ethanol-
fed rats (Figures 4A,B). ACEA and JWH133 increased the
percentage of BrdU+ cells in the hypothalamus of sucrose-fed
rats (Figure 4C). ACEA increased the percentage of BrdU+ cells
in the SVZ, SGZ, and hypothalamus of ethanol-fed rats (#P <
0.05; Figures 4A–C). Representative images of the labeling in the
SVZ, SGZ, and hypothalamus of each experimental group are
shown in Figures 4D–Z′.
Phenotyping of Neural Proliferating Cells
We evaluated the percentage of BrdU+ cells showing a precursor
(GFAP or phospho-H3 expression) or mature neuronal (β3-
tubulin) phenotype to characterize the neural proliferating cells
in the main neurogenic zones of ACEA- and JWH133-treated
rats. We detected a very low number and a lack of BrdU+
cells expressing the mitotic marker phospho-H3 in the SVZ
and hypothalamus, respectively (Figures 5A,C). In contrast,
alcohol-exposed rats treated with JWH133, but not the other
treatments, exhibited BrdU+ cells that expressed phospho-H3
in the SGZ (Figure 5B). Representative images of BrdU and
phospho-H3 labeling in the SVZ, SGZ, and hypothalamus of each
experimental group are shown in Figures 5D–U.
The SGZ and hypothalamus of the rats exposed to alcohol
exhibited BrdU+ cells that expressed the radial/astrocyte
precursor GFAP, which was not detected when alcohol-exposed
FIGURE 4 | Effects of the repeated administration of URB597 (0.3mg/kg), ACEA (3mg/kg), and JWH133 (0.2mg/kg) on cells that contained the
replicating cell DNA marker 5-bromo-2′-deoxyuridine (BrdU+) in the SVZ (A), SGZ (B), and hypothalamus (C) of adult rats with sucrose and alcohol
consumption. The data were expressed as the percentage of positive cells per area (mm2) relative to the control group (vehicle-treated sucrose-fed group). The
histograms represents the mean + s.e.m. (n = 6). Bonferroni’s test: *P < 0.05, **P < 0.01, ***P < 0.001 vs. sucrose-vehicle group; #P < 0.05, ###P < 0.001 vs.
ethanol-vehicle group. (D–Z′) Representative microphotographs showing low and high (insets) magnification views of the typical clustering of newborn cells containing
the BrdU labeling (arrowheads) in the SGZ, SVZ, and hypothalamus of vehicle, URB597, ACEA, and JWH133-treated rats fed with sucrose (left panel) and ethanol
(right panel) diets. Scale bars are included in each image.
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FIGURE 5 | Quantification of the proportion of cells labeled with BrdU that expressed phospho-H3 in the SVZ (A), SGZ (B), and hypothalamus (C) of
vehicle, ACEA and JWH133-treated rats fed with sucrose and ethanol diets. Bars represent the percentage of labeled cells in each experimental group. (D–U)
BrdU and phospho-H3 co-expression in the rat brain. High-resolution confocal laser scanning photomicrographs showing the labeling of BrdU (green) and
phospho-H3 (red) in the SVZ, SGZ, and hypothalamus of vehicle, ACEA and JWH133-treated rats fed with sucrose (left panel) and ethanol (right panel) diets. The
arrowheads indicate co-expression. Scale bars are included in the left-upper images.
rats were treated with JWH133 (Figures 6B,C). No co-expression
of BrdU and GFAP in the SVZ was observed (Figure 6A).
Representative images of the BrdU andGFAP labeling in the SVZ,
SGZ, and hypothalamus of each experimental group are shown in
Figures 6D–U.
All rat groups treated with JWH133 exhibited an increased
number of BrdU+ cells that expressed the neuron-specific
β3-tubulin in the SVZ and SGZ (Figures 7A,B). No co-
expression of BrdU and β3-tubulin in the hypothalamus was
observed (Figure 7C). Representative images of BrdU and β3-
tubulin labeling in the SVZ, SGZ, and hypothalamus of each
experimental group are shown in Figures 7D–U.
Discussion
The present study demonstrated that URB597 and ACEA
increased alcohol consumption likely via CB1 receptor activation,
but the selective stimulation of CB1 and CB2 receptors using
ACEA and JWH133 actively counteracted the alcohol-induced
decrease in NPC proliferation in the brain of adult rats with
a forced consumption of alcohol (Figure 8). Data analyses
revealed treatment effects on cell proliferation in a neurogenic
region-dependent manner. Therefore, we reached the following
conclusions: (1) ACEA and JWH133 induced an increase in
NPC proliferation (phospho-H3+ and BrdU+ cells) in the
SGZ of the alcohol-exposed rats, which indicates a non-
selective cannabinoid receptor-dependent stimulation of SGZ
cell proliferation, and (2) JWH133 also produced a specific
increase in NPC proliferation (phospho-H3+ and BrdU+
cells) in the SVZ of alcohol-exposed rats, which indicates
a selective CB2 receptor activation of SVZ cell proliferation.
The increased cell proliferation after CB2 receptor activation
may be related to an improvement in adult neurogenesis
because JWH133 induced numerous BrdU+ cells that expressed
neuron-specific β3-tubulin in the SGZ and SVZ. The effects
of JWH133 on neurogenesis must be contextualized with
the lack of significant increase in alcohol consumption and,
as a probable consequence, the reduced concentration of
bilirubin and creatinine in the plasma of alcohol-exposed rats,
which indicates an amelioration of the hepatic anti-oxidant
activity and renal filtration, respectively. This information
suggests that CB2 receptor activation by JWH133 is the
most suitable strategy to counteract the toxicity effects of
alcohol on neurogenesis in the two main neurogenic zones
(SGZ and SVZ) of the adult brain. However, the increase
in BrdU+ cells, but not phospho-H3+ cells, in the SVZ
and hypothalamus by the selective CB1 receptor agonist
ACEA suggests a less potent recovery of cell proliferation
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FIGURE 6 | Quantification of the proportion of cells labeled with BrdU that expressed GFAP in the SVZ (A), SGZ (B), and hypothalamus (C) of vehicle,
ACEA and JWH133-treated rats fed with sucrose and ethanol diets. Bars represent the percentage of labeled cells in each experimental group. (D–U) BrdU
and GFAP co-expression in the rat brain. High-resolution confocal laser scanning photomicrographs showing the labeling of BrdU (green) and GFAP (red) in the SVZ,
SGZ, and hypothalamus of vehicle, ACEA and JWH133-treated rats fed with sucrose (left panel) and ethanol (right panel) diets. The arrowheads indicate
co-expression. Scale bars are included in the left-upper images.
in alcohol-exposed rat brain. Selective stimulation of the
cannabinoid CB1 and CB2 receptors also increased NPC
proliferation in a neurogenic region-dependent manner in rats
fed a sucrose liquid diet. Notably, the most consistent results
also highlighted the effects of CB2 receptor activation on
the brain of sucrose-fed rats because JWH133 increased NPC
proliferation (phospho-H3+ and BrdU+ cells) in the SGZ, SVZ,
and hypothalamus.
Our results are consistent with previous studies that
demonstrated the following results: (1) an in vitro promotion
of the neurosphere generation and an in vivo stimulation of
hippocampal NPC proliferation by WIN 55,212-2 and AEA
(Aguado et al., 2005); (2) an increased number of Ki67+ cells
in the SVZ of mice treated with JWH133 and WIN 55,212-2;
and (3) a decreased number of Ki67+ cells in the SVZ of mice
treated with the CB2 receptor antagonists AM630 and JTE-907
(Goncalves et al., 2008). Our results provide inconclusive results
on the URB597 effect on NPC proliferation in the SGZ and
SVZ, which is consistent with previous studies. An increased
proliferation of neural progenitors (BrdU+ and/or Ki67+ cells)
was described in the hippocampus of FAAH−/− mice, the SVZ
of URB597-treated mice and the neurospheres treated in vitro by
URB597 (3 nM; Aguado et al., 2005; Goncalves et al., 2008). In
contrast, a recent study by Rivera et al. (2015) demonstrated that
acute treatment with URB597 (0.3mg/kg) increased the number
of phospho-H3+ and BrdU+ cells specifically in the SVZ of
the adult rat brain, but no change was detected in the SGZ.
These authors demonstrated that the repeated administration
of URB597 specifically reduced NPC proliferation in the SGZ
of the adult rat brain (Rivera et al., 2015). URB597 at a dose
of 0.3mg/kg maximally blocked FAAH activity and increased
plasma and brain levels of AEA in alcohol-exposed rats (see
Figure S1), but the same neurogenic effect was not produced
in the SGZ using ACEA or JWH133. Therefore, we postulated
that the differential effects of URB597 on NPC proliferation
may be a consequence of the conjunction of multiple factors,
such as the different catalytic properties of FAAH, depending
on substrate specificity (e.g., anandamide, oleoylethanolamide,
and palmithylethanolamide), the cell types that express FAAH
(e.g., FAAH is highly expressed in the hippocampus and lowly
expressed in the hypothalamus), and the physiopathological
conditions of the experimental model (Sun et al., 2005; Ohno-
Shosaku and Kano, 2014).
Our results demonstrated similar effects of URB597 and
ACEA on sucrose and alcohol consumption, which suggests
an indiscriminate consumption response via CB1 receptor
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FIGURE 7 | Quantification of the proportion of cells labeled with BrdU that expressed β3-tubulin in the SVZ (A), SGZ (B), and hypothalamus (C) of
vehicle, ACEA and JWH133-treated rats fed with sucrose and ethanol diets. Bars represent the percentage of labeled cells in each experimental group. (D–U)
BrdU and β3-tubulin co-expression in the rat brain. High-resolution confocal laser scanning photomicrographs showing the labeling of BrdU (green) and β3-tubulin
(red) in the SVZ, SGZ, and hypothalamus of vehicle, ACEA and JWH133-treated rats fed with sucrose (left panel) and ethanol (right panel) diets. The arrowheads
indicate co-expression. Scale bars are included in the left-upper images.
activation, but JWH133 did not demonstrate a specific effect
on ethanol intake. In contrast to the increased sucrose intake
after CB2 receptor stimulation, our results demonstrated a
very low influence of JWH133 (and thus cannabinoid CB2
receptors) in forced alcohol consumption. These results agree
with the contradictory responses of cannabinoid signaling
in the promotion of voluntary alcohol consumption and
the low motor performance-induced blockade of operant
alcohol self-administration (Serrano and Parsons, 2011).
The following previous results were described: (1) WIN
55,212-2 and CP 55,940 promote voluntary ethanol intake
in sP rats (Colombo et al., 2002); (2) ACEA, WIN 55,212-2,
AM404, and URB597 reduce alcohol self-administration,
which likely indicates a compensation/substitution of the
reinforcing effects of ethanol (Cippitelli et al., 2007); and
3) CB1−/− mice consumed less alcohol, and the CB1
receptor antagonist SR141716A blocked the dopamine-
releasing effects of alcohol and reduced operant alcohol
self-administration (Hungund et al., 2003; Crabbe et al.,
2006; Hansson et al., 2007). These studies contrast with other
studies that showed that CB2 receptor agonists reduced alcohol
preference in mice (Vasiljevik et al., 2013; Al Mansouri et al.,
2014).
The increased concentration of hepatic transaminases in the
plasma of alcohol-exposed rats should be associated with an
alcohol-induced decrease in BrdU+ cells, but not phospho-H3+
cells, in the three neurogenic zones analyzed (SGZ, SVZ, and
hypothalamus). We proposed three non-exclusive hypothesis
to explain the differential effects of alcohol on phospho-H3+
and BrdU+ cells: (1) the basal low rate of phospho-H3+ cell
production could hide the deleterious effect of ethanol; (2) the
average ethanol intake of 7.3± 1.1 g/kg/day for the last 6 days did
not produce a relevant deleterious effect on the rate of phospho-
H3+ cells; and (3) BrdU+ cells that represent neuroblasts and
young immature neurons exhibited a higher vulnerability to
alcohol toxicity and a higher risk of cell death (Deng et al.,
2010).
In summary, the present study demonstrated that selective
CB2 receptor agonist JWH133 counteracted the deleterious effect
of alcohol on NPC proliferation in the SGZ and SVZ, but
the selective CB1 receptor agonist ACEA only reversed the
impaired NPC proliferation in the SGZ. ACEA increased alcohol
consumption, but JWH133 did not, which suggests that the
activation of CB2 receptors is of potential clinical interest for the
risk of neural damage in alcohol dependence. Further studies are
required to assess whether the effects of selective cannabinoid
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FIGURE 8 | Schematic representation that summarize the main effects
of alcohol, ACEA and JWH133 on cell proliferation and neuronal
maturation. (A) Ethanol reduced the number of proliferative cells and, as a
consequence, the number of cell showing neuronal phenotype. (B) ACEA and
JWH can block the deleterious effects of alcohol as they increased the number
of proliferative cells and the putative mature neurons.
CB1/CB2 stimulation on neurogenesis can induce the recovery
of hippocampal-dependent tasks in alcoholic patients.
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